IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q3 2017 Holdings

Filed 2017-11-14 | 17 holdings | $89.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corvus Pharmaceuticals Inc(CRVS)COM221015100$51.7M3,244,04657.8%
Akebia Therapeutics Inc(AKBA)COM00972D105$37.1M1,887,53541.5%
Inogen Inc(INGN)COM45780L104$337.5K3,549,3200.4%
Acceleron Pharma Inc(XLRN)COM00434H108$58.0K1,553,9370.1%
Dermira Inc(DERMEUR)COM24983L104$51.9K1,921,5800.1%
Anaptysbio Inc(ANAB)COM032724106$41.6K1,190,6040.0%
Flexion Therapeutics IncCOM33938J106$36.3K1,500,0000.0%
RA Pharmaceuticals IncCOM74933V108$29.7K2,031,5620.0%
Merus N VCOMN5749R100$28.0K1,410,4170.0%
Nabriva Therapeutics PLCSHSG63637105$23.8K2,903,8000.0%
Reata Pharmaceuticals Inc(RETAEUR)CL A75615P103$18.4K592,7940.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$18.3K2,725,2830.0%
Invuity IncCOM NEW46187J205$12.1K1,363,8480.0%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$11.4K740,7400.0%
Wright MED Group N VRIGHT 03/01/2019N96617126$7.2K$4,622,0320.0%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$4.0K223,3170.0%
Apollo Endosurgery Inc(HQ8F)COM03767D108$1.3K274,4720.0%